0.0001
前日終値:
$0.0003
開ける:
$1E-06
24時間の取引高:
178.62K
Relative Volume:
3.98
時価総額:
$N/A
収益:
-
当期純損益:
$-30.72M
株価収益率:
-0.00011
EPS:
-0.9105
ネットキャッシュフロー:
$-4.05M
1週間 パフォーマンス:
-66.67%
1か月 パフォーマンス:
-83.33%
6か月 パフォーマンス:
-93.75%
1年 パフォーマンス:
-99.22%
Ocean Biomedical Inc Stock (OCEA) Company Profile
Compare OCEA vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
OCEA
Ocean Biomedical Inc
|
0.0001 | 0 | 0 | -30.72M | -4.05M | -0.9105 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.54 | 113.70B | 12.34B | 4.34B | 3.71B | 16.87 |
|
REGN
Regeneron Pharmaceuticals Inc
|
614.78 | 65.16B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
835.99 | 52.14B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
301.98 | 40.73B | 4.29B | 577.22M | 641.34M | 4.2086 |
|
RVMD
Revolution Medicines Inc
|
157.48 | 32.87B | 742.00K | -1.37B | -1.07B | -7.0731 |
Ocean Biomedical Inc (OCEA) 最新ニュース
Deep-sea fish's light-scattering crystals could inspire new biomedical devices - Interesting Engineering
Ocean Biomedical, Inc.Common Stock (NQ: OCEA - The Chronicle-Journal
DcashLanzillotta.166300 User Profile @ StockInvest.us - StockInvest.us
Ocean Biomedical, Inc. (OCEAW) - Minichart
Stock List: Research Stocks from Around the World - GuruFocus
OCEA (Ocean Biomedical) PB Ratio : (As of Apr. 07, 2026) - GuruFocus
OCEAW (Ocean Biomedical) PB Ratio : (As of Apr. 04, 2026) - GuruFocus
Top 10 Best Paying Marine Biology Jobs 2026 (Inc Salaries) - Nexford University
Ocean Biomedical, Inc. (OCEA) stock price, news, quote and history - Yahoo Finance UK
LakeShore Biopharma Co., Ltd (LSBWF) stock price, news, quote and history - Yahoo Finance UK
Ocean Biomedical expands into energy and digital asset sectors - MSN
Biotech Companies are Coming to Life at Ocean State Labs - Rhode Island Monthly
Pharmaceutical companies move away from horseshoe crab biomedical testing - Mongabay
OCEAW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
OCEA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Clearside Bio Wants Block On $100M Bid That 'Froze' Auction - Law360
How forex fluctuations impact Ocean Biomedical Inc. (8AW0) stockJuly 2025 Reactions & Smart Allocation Stock Tips - mfd.ru
Orthocell lifts Marine Biomedical stake, locks in rights to PearlBone bone substitute | ASX:OCC, OTC:ORHHF - Proactive financial news
Why Intuitive Machines Shares Are Trading Lower By Around 30%; Here Are 20 Stocks Moving Premarket - Intellectia AI
Published on: 2026-01-12 03:41:29 - Bộ Nội Vụ
OCEA Stock Price, Quote and News - Markets.com
Published on: 2026-01-07 16:42:30 - Bộ Nội Vụ
Published on: 2026-01-05 02:15:00 - earlytimes.in
Jubilant Agri And Consumer Products Limited Stages Intraday Comeback Trend ChangeStock Price Forecasts & Affordable Portfolio Building - earlytimes.in
Published on: 2026-01-03 03:23:53 - moha.gov.vn
Clearside Biomedical receives court approval for asset sale bidding procedures - Investing.com
What drives Ocean Biomedical Inc 8AW0 stock priceMarket Correction Analysis & Rapid Capital Gain - earlytimes.in
Will Ocean Biomedical Inc. (8AW0) stock hit analyst forecastsMarket Activity Recap & Stepwise Entry/Exit Trade Alerts - Улправда
Amira’s AMI-463 demonstrates 60% tumor reduction in mouse model - bioworld.com
India's first deep sea marine microbial research facility coming up in Andhra's Nellore - The Economic Times
Why Ocean Biomedical Inc. (8AW0) stock stays undervaluedJuly 2025 Short Interest & Breakout Confirmation Trade Signals - Newser
Biotech Stocks Are Tumbling — But The Top 5 Are Standouts - Investor's Business Daily
What analyst consensus implies for Ocean Biomedical Inc. (8AW0) stock2025 Trading Volume Trends & Accurate Entry/Exit Alerts - Newser
Will Ocean Biomedical Inc. (8AW0) stock outperform value peersQuarterly Risk Review & Smart Money Movement Alerts - Newser
Ocean Dx sepsis test matches gold standard in early study - BioWorld News
Orthocell ups Marine Biomedical stake, targeting PearlBone™ global rights and the US$1.6BN bone substitutes market - Proactive financial news
Idiopathic Pulmonary Fibrosis Pipeline Drugs Insights Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight - The Globe and Mail
SPACs, Executives Beat Investor’s Shell Company Accusations (1) - Bloomberg Law News
Orchestra BioMed stock rating downgraded to Neutral from Buy by BTIG - Investing.com
From Ocean to Industry: How Fresh on Time Seafood Excels as a Chitosan Manufacturer - Digital Journal
Delisting of Securities from The Nasdaq Stock Market - The Manila Times
Orchestra BioMed director Hochman buys $55,000 in OBIO stock - Investing.com
Ocean Biomedical to be delisted from Nasdaq following appeal denial - Investing.com
Ocean Biomedical licenses with Elkurt terminated following breach notice - Investing.com
Nasdaq closes lower, weighed by tech stocks, Dow ends sharply higher - marketscreener.com
Horseshoe crabs belong in the ocean, not in labs - Humane World for Animals
SEC filing of the week: Ocean Biomedical faces loss of licensing agreements - Providence Business News
Ocean Biomedical faces license terminations over breaches - Investing.com
IPO Tracker (2021) - Endpoints News
Southern Ocean Medical Center Just Days Away from Potential Nurses Strike - The SandPaper
Ocean Biomedical, Inc. SEC 10-Q Report - TradingView — Track All Markets
Ocean Biomedical Inc (OCEA) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):